Startup

Rheon Medical

Description

Rheon Medical, a spin-off from the Swiss Federal Institute of Technology Lausanne (EPFL), is dedicated to revolutionizing the surgical treatment of glaucoma. Their flagship product, the eyeWatch system, is an adjustable glaucoma drainage device that offers a state-of-the-art solution for patients with refractory glaucoma. By allowing for non-invasive adjustment of intraocular pressure, the eyeWatch system has shown unprecedented success in reducing IOP, minimizing the need for anti-glaucoma drugs, and preventing hypotony. With a strong team of experts and a focus on developing novel technologies to improve treatment efficacy and patient outcomes, Rheon Medical aims to become a global leader in the glaucoma device market.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.